Development of robust antiviral assays using relevant apical-out human airway organoids is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0.345. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1R01HL139876-01
Rare mutations in Cystic Fibrosis: Overcoming barriers to personalized medicine
National Institutes of Health
Grant: 5R01HL136141-04
Microfluidic Tissue Engineering of Small Airway Injuries
National Institutes of Health
Grant: 5R01AI161570-02
Broad-spectrum therapeutics against SARS-CoV-2 3CL protease
National Institutes of Health
Grant: 5P30AI050409-20
Center for AIDS Research at Emory University
National Science Foundation
Grant: 0939511
NSF Science and Technology Center: Emergent Behaviors of Integrated Cellular Systems
NIAID NIH HHS
Grant: P30 AI050409
NIAID NIH HHS
Grant: R01 AI161570
NHLBI NIH HHS
Grant: R01 HL136141
NHLBI NIH HHS
Grant: R01 HL139876
Fields of Study
Keywords
Sustainable Development Goals